Helicos BioSciences Corporation (NASDAQ: HLCS) is a publicly traded life science company focused on innovative genetic analysis technologies for the development and marketing of molecular diagnostics tests. Helicos' proprietary True Single Molecule Sequencing technology allows the direct measurement of natural DNA without the confounding steps of sample manipulation or nucleic acid amplification. Helicos is a Flagship VentureLabs^TM company.